Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Plasma cell 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 20Lymphoma 5Neoplasms, Plasma Cell 4Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Smoldering Multiple Myeloma 1Sarcoma 1Paraproteinemias 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Disease 1Carcinoma 1Amyloidosis 1Alzheimer Disease 1

Interventions

molibresib 1Injections 1Blood Specimen Collection 1Ascorbic Acid 13-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 11-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Blood Specimen Collection × Plasma cell × Clear all
NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
11 enrolled
DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡